{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T08:49:41Z","timestamp":1789462181228,"version":"build-2803163510"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T00:00:00Z","timestamp":1771718400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Preventive Cardiology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.ajpc.2026.101499","type":"journal-article","created":{"date-parts":[[2026,3,7]],"date-time":"2026-03-07T12:12:25Z","timestamp":1772885545000},"page":"101499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["A polypill strategy for lipid lowering and anti-platelet therapy after acute coronary syndrome: A pilot randomized controlled trial"],"prefix":"10.1016","volume":"27","author":[{"given":"Juan David","family":"Coellar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Keshvani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand K.","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Shariq","family":"Usman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew W.","family":"Segar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James W.","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Bustillo-Rubio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharam J.","family":"Kumbhani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohanakrishnan","family":"Sathyamoorthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhash","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Yates","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J.","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambarish","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"8","key":"10.1016\/j.ajpc.2026.101499_bib0001","doi-asserted-by":"crossref","first-page":"e153","DOI":"10.1161\/CIR.0000000000001052","article-title":"Heart disease and stroke statistics-2022 update: a report from the American Heart Association","volume":"145","author":"Tsao","year":"2022","journal-title":"Circulation"},{"issue":"9","key":"10.1016\/j.ajpc.2026.101499_bib0002","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.022198","article-title":"Event rates and risk factors for recurrent cardiovascular events and mortality in a contemporary post acute coronary syndrome population representing 239 234 patients during 2005 to 2018 in the United States","volume":"11","author":"Steen","year":"2022","journal-title":"J Am Heart Assoc"},{"issue":"13","key":"10.1016\/j.ajpc.2026.101499_bib0003","first-page":"e771","article-title":"2025 ACC\/AHA\/ACEP\/NAEMSP\/SCAI guideline for the management of patients with acute coronary syndromes: a report of the American College of Cardiology\/American Heart Association Joint Committee on clinical practice guidelines","volume":"151","author":"Rao","year":"2025","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ajpc.2026.101499_bib0004","article-title":"Antiplatelet strategies following PCI: a review of trials informing current and future therapies","volume":"2","author":"Thomas","year":"2023","journal-title":"J Soc Cardiovasc Angiogr Interv"},{"issue":"5","key":"10.1016\/j.ajpc.2026.101499_bib0005","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1001\/jama.299.5.532","article-title":"Incidence of death and acute myocardial infarction associated with stopping clopidogrel after acute coronary syndrome","volume":"299","author":"Ho","year":"2008","journal-title":"JAMA"},{"issue":"24","key":"10.1016\/j.ajpc.2026.101499_bib0006","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1161\/CIRCULATIONAHA.106.618066","article-title":"Prevalence, predictors, and outcomes of premature discontinuation of thienopyridine therapy after drug-eluting stent placement: results from the PREMIER registry","volume":"113","author":"Spertus","year":"2006","journal-title":"Circulation"},{"issue":"4","key":"10.1016\/j.ajpc.2026.101499_bib0007","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1161\/CIRCOUTCOMES.114.001223","volume":"8","author":"Mathews","year":"2015","journal-title":"Circ Cardiovasc Qual Outcomes"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101499_bib0008","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.010376","article-title":"Adherence to statin therapy among US adults between 2007 and 2014","volume":"8","author":"Colantonio","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"10.1016\/j.ajpc.2026.101499_bib0009","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/s11606-014-3072-x","article-title":"Medication non-adherence after myocardial infarction: an exploration of modifying factors","volume":"30","author":"Crowley","year":"2015","journal-title":"J Gen Intern Med"},{"issue":"7","key":"10.1016\/j.ajpc.2026.101499_bib0010","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jamainternmed.2018.0783","article-title":"Trends in platelet adenosine diphosphate P2Y12 receptor inhibitor use and adherence among antiplatelet-naive patients after percutaneous coronary intervention, 2008-2016","volume":"178","author":"Dayoub","year":"2018","journal-title":"JAMA Intern Med"},{"issue":"20","key":"10.1016\/j.ajpc.2026.101499_bib0011","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1161\/CIRCULATIONAHA.117.029160","article-title":"Hospital variation in adherence rates to secondary prevention medications and the implications on quality","volume":"137","author":"Mathews","year":"2018","journal-title":"Circulation"},{"issue":"3","key":"10.1016\/j.ajpc.2026.101499_bib0012","doi-asserted-by":"crossref","first-page":"E171","DOI":"10.25270\/jic\/21.00055","article-title":"Identifying racial, ethnic, and socioeconomic inequities in the use of novel P2Y12 inhibitors after percutaneous coronary intervention","volume":"34","author":"Nathan","year":"2022","journal-title":"J Invasive Cardiol"},{"issue":"4","key":"10.1016\/j.ajpc.2026.101499_bib0013","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1038\/s41591-024-02896-w","article-title":"Fixed-dose combination therapy for the prevention of atherosclerotic cardiovascular disease","volume":"30","author":"Agarwal","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/j.ajpc.2026.101499_bib0014","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.pcad.2022.01.005","article-title":"Association of polypill therapy with cardiovascular outcomes, mortality, and adherence: a systematic review and meta-analysis of randomized controlled trials","volume":"73","author":"Rao","year":"2022","journal-title":"Prog Cardiovasc Dis"},{"issue":"11","key":"10.1016\/j.ajpc.2026.101499_bib0015","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1056\/NEJMoa2208275","article-title":"Polypill strategy in secondary cardiovascular prevention","volume":"387","author":"Castellano","year":"2022","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.ajpc.2026.101499_bib0016","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"issue":"7","key":"10.1016\/j.ajpc.2026.101499_bib0017","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1080\/09537100701280654","article-title":"Clopidogrel anti-platelet effect: an evaluation by optical aggregometry, impedance aggregometry, and the platelet function analyzer (PFA-100)","volume":"18","author":"Dyszkiewicz-Korpanty","year":"2007","journal-title":"Platelets"},{"issue":"11","key":"10.1016\/j.ajpc.2026.101499_bib0018","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0187139","article-title":"Accuracy of a screening tool for medication adherence: a systematic review and meta-analysis of the Morisky Medication Adherence Scale-8","volume":"12","author":"Moon","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/j.ajpc.2026.101499_bib0019","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1477-7525-2-12","article-title":"Validation of a general measure of treatment satisfaction, the treatment satisfaction questionnaire for medication (TSQM), using a national panel study of chronic disease","volume":"2","author":"Atkinson","year":"2004","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/j.ajpc.2026.101499_bib0020","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.vhri.2020.07.578","article-title":"Treatment satisfaction questionnaire for medication (TSQM version 1.4): ceiling and floor effects, reliability, and known-group validity in Brazilian outpatients with hypertension","volume":"23","author":"Liberato","year":"2020","journal-title":"Value Health Reg Issues"},{"issue":"2","key":"10.1016\/j.ajpc.2026.101499_bib0021","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0735-1097(94)00397-9","article-title":"Development and evaluation of the Seattle angina questionnaire: a new functional status measure for coronary artery disease","volume":"25","author":"Spertus","year":"1995","journal-title":"J Am Coll Cardiol"},{"issue":"12","key":"10.1016\/j.ajpc.2026.101499_bib0022","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1056\/NEJMoa1815359","article-title":"Polypill for cardiovascular disease prevention in an underserved population","volume":"381","author":"Munoz","year":"2019","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.ajpc.2026.101499_bib0023","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1056\/NEJMoa2028220","article-title":"Polypill with or without aspirin in persons without cardiovascular disease","volume":"384","author":"Yusuf","year":"2021","journal-title":"N Engl J Med"},{"issue":"10199","key":"10.1016\/j.ajpc.2026.101499_bib0024","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0140-6736(19)31791-X","article-title":"Effectiveness of polypill for primary and secondary prevention of cardiovascular diseases (PolyIran): a pragmatic, cluster-randomised trial","volume":"394","author":"Roshandel","year":"2019","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.ajpc.2026.101499_bib0025","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1001\/jamacardio.2017.0911","article-title":"Adherence to high-intensity statins following a myocardial infarction hospitalization among Medicare beneficiaries","volume":"2","author":"Colantonio","year":"2017","journal-title":"JAMA Cardiol"},{"issue":"16","key":"10.1016\/j.ajpc.2026.101499_bib0026","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1093\/eurjpc\/zwad245","article-title":"Polypill-based strategy vs. usual care for secondary prevention of cardiovascular disease: a meta-analysis of randomized controlled trials","volume":"30","author":"Rivera","year":"2023","journal-title":"Eur J Prev Cardiol"},{"issue":"4","key":"10.1016\/j.ajpc.2026.101499_bib0027","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1161\/CIRCULATIONAHA.122.059661","article-title":"Should polypills Be used for heart failure with reduced ejection fraction?","volume":"146","author":"Pandey","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/j.ajpc.2026.101499_bib0028","article-title":"Design, and baseline characteristics of the polypill for heart failure with reduced ejection fraction (POLY-HF) trial","author":"Keshvani","year":"2025","journal-title":"J Card Fail"}],"container-title":["American Journal of Preventive Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726000930?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2666667726000930?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T11:20:24Z","timestamp":1789039224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2666667726000930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":28,"alternative-id":["S2666667726000930"],"URL":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101499","relation":{},"ISSN":["2666-6677"],"issn-type":[{"value":"2666-6677","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A polypill strategy for lipid lowering and anti-platelet therapy after acute coronary syndrome: A pilot randomized controlled trial","name":"articletitle","label":"Article Title"},{"value":"American Journal of Preventive Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101499","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ajpc.2026.101500","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"101499"}}